Mikel Ross on Patient Tolerability of Cooling Caps for Chemotherapy-Induced Hair Loss
Mikel Ross discusses the cooling cap intervention for chemotherapy-induced hair loss and patients' tolerability.
Mikel Ross, BSN, RN, OCN, from Memorial Sloan Kettering Cancer Center, discusses the cooling cap intervention for chemotherapy-induced hair loss and how patients tolerated the treatment.
Patients seem to tolerate this intervention well. However, it does add time to the chemotherapy process, as a pre-cooling and post-cooling period is required. This time commitment is likely the main reason for discontinuation. Otherwise, there only seems to be a cold sensation that patients have reported.